Overview
Gastric ulcers caused by drugs, particularly nonsteroidal anti-inflammatory drugs (NSAIDs), result from mucosal damage and impaired healing mechanisms, often exacerbated by factors like Helicobacter pylori infection and reduced prostaglandin synthesis. 13Diagnosis
Clinical Presentation: Epigastric pain, often relieved by food or antacids.
Endoscopy: Visualization of ulceration in the stomach.
Laboratory Tests: Complete blood count, liver function tests; urea breath test or stool antigen test for H. pylori if suspected 13.
Histology: Not typically required unless complications are suspected.
Medication History: Essential to identify potential causative drugs like NSAIDs.
H. pylori Testing: Recommended in patients with NSAID-associated ulcers to guide eradication therapy 3.Management
Discontinue Causative Drugs: Stop or switch to alternative NSAIDs with gastroprotective properties (e.g., COX-2 inhibitors) if possible.
Proton Pump Inhibitors (PPIs): First-line therapy; high-dose PPIs (e.g., omeprazole 40 mg daily) for healing.
H2 Receptor Antagonists: Adjunctive therapy if PPIs are contraindicated or insufficient.
H. pylori Eradication: Triple therapy (PPI, clarithromycin, amoxicillin or metronidazole) if H. pylori infection is present 3.
Protective Agents: Misoprostol or prostaglandin analogs to reduce mucosal damage in high-risk patients.
Monitoring: Regular follow-up with endoscopy to assess healing and recurrence.Special Populations
Pregnancy: Avoid NSAIDs; use PPIs cautiously, preferring safer alternatives like H2 blockers 3.
Elderly: Increased risk of complications; careful monitoring and dose adjustment of medications necessary 3.
Comorbidities: Consider interactions with concurrent medications; H. pylori testing and eradication crucial if applicable 3.Key Recommendations
Discontinue or Replace Causative NSAIDs to prevent further gastric mucosal damage (Evidence: Expert opinion 3).
Initiate High-Dose PPI Therapy for healing of NSAID-induced gastric ulcers (Evidence: Expert opinion 3).
Test for and Eradicate H. pylori in patients with NSAID-associated ulcers to improve healing outcomes (Evidence: Expert opinion 3).References
1 Cierniewski CS, Swiatkowska M, Poniatowski J, Niewiarowska J. Anti-(Arg-Gly-Asp-Ser) antibody and its interaction with fibronectin, fibrinogen and platelets. European journal of biochemistry 1988. link
2 Mahony C. The ultrasonic detection of platelet aggregates. Thrombosis research 1987. link90105-8)
3 Courtois G, Ryckewaert JJ, Woods VL, Ginsberg MH, Plow EF, Marguerie GA. Expression of intracellular fibrinogen on the surface of stimulated platelets. European journal of biochemistry 1986. link